Although patients in the basal-bolus group received almost three times the daily insulin dose of patients in the SSI group, only two patients in each group had a hypoglycemic event, and none of ...

Inclusion of basal insulin glargine in multiple daily injection (MDI) regimens decreases glycemic variability in adolescents with type 1 diabetes mellitus (T1DM), according to US researchers.